| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 21.05.
| Sangamo BioSciences And Collaborators Highlight Widening Applications Of ZFP Therapeutics® In Presentations At Major Gene Therapy Meeting | | 47 | PR Newswire |
| RICHMOND, Calif., May 21, 2012 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development...
Mehr lesen zu:
Sangamo BioSciences And Collaborators Highlight Widening Applications Of ZFP Therapeutics® In Presentations At Major Gene Therapy Meeting | |
| 17.05.
| Sangamo BioSciences' CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript) | | 15 | Seeking Alpha |
| 07.05.
| SANGAMO BIOSCIENCES INC - 10-Q, Quarterly Report | | 25 | SEC Filings |
| 07.05.
| Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences | | 52 | PR Newswire |
| RICHMOND, Calif., May 7, 2012 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's...
Mehr lesen zu:
Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences | |
| 03.05.
| Sangamo's CEO Discusses Q1 2012 Results - Earnings Call Transcript | | 21 | Seeking Alpha |
| 02.05.
| Sangamo BioSciences Reports First Quarter 2012 Financial Results | | 46 | PR Newswire |
| RICHMOND, Calif., May 2, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported first quarter 2012 financial results and accomplishments.
For the first quarter ended March...
Mehr lesen zu:
Sangamo BioSciences Reports First Quarter 2012 Financial Results | |
| 30.04.
| Sangamo BioSciences Nominates Saira Ramasastry To The Company's Board Of Directors | | 32 | PR Newswire |
| RICHMOND, Calif., April 30, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in the development of novel zinc finger DNA-binding proteins (ZFPs) for therapeutic gene modification...
Mehr lesen zu:
Sangamo BioSciences Nominates Saira Ramasastry To The Company's Board Of Directors | |
| 25.04.
| Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast | | 55 | PR Newswire |
| RICHMOND, Calif., April 25, 2012 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its first quarter 2012 financial results on Wednesday, May 2...
Mehr lesen zu:
Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast | |
| 12.04.
| Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference | | 82 | PR Newswire |
| RICHMOND, Calif., April 12, 2012 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of...
Mehr lesen zu:
Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference | |
| 02.04.
| 58.1% Return Seen to Date on SmarTrend Sangamo Biosciences Call | | 36 | SmarTrend |
| 02.04.
| Sangamo BioSciences (SGMO) Reports Publication of Preclinical ZFN Data | | 22 | StreetInsider.com |
| 02.04.
| Sangamo BioSciences Announces Publication in Nature Medicine Demonstrating Use of ZFN Technology to Engineer Safer and More Effective Cancer Treatments | | 50 | PR Newswire |
| RICHMOND, Calif., April 2, 2012 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of a preclinical study demonstrating the use of zinc finger nucleases (ZFNs)...
Mehr lesen zu:
Sangamo BioSciences Announces Publication in Nature Medicine Demonstrating Use of ZFN Technology to Engineer Safer and More Effective Cancer Treatments | |
| 30.03.
| Lowest Sales Growth in the Biotechnology Industry Detected in Shares of Sangamo Biosciences | | 22 | SmarTrend |
| 28.03.
| Sangamo BioSciences Announces Presentation at Needham Healthcare Conference | | 48 | PR Newswire |
| RICHMOND, Calif., March 28, 2012 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of...
Mehr lesen zu:
Sangamo BioSciences Announces Presentation at Needham Healthcare Conference | |
| 08.03.
| Sangamo Presents New Clinical Data at CROI 2012 Demonstrating Persistent Positive Effects of ZFN Therapeutic® for "Functional Cure" of HIV/AIDS | | 115 | PR Newswire |
| RICHMOND, Calif., March 8, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that new data from its program to develop a 'functional cure' for HIV/AIDS were described...
Mehr lesen zu:
Sangamo Presents New Clinical Data at CROI 2012 Demonstrating Persistent Positive Effects of ZFN Therapeutic® for "Functional Cure" of HIV/AIDS | |
| 09.02.
| Sangamo BioSciences Announces Presentation at 2012 Leerink Swann Global Healthcare Conference | | 78 | PR Newswire |
| RICHMOND, Calif., Feb. 9, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the...
Mehr lesen zu:
Sangamo BioSciences Announces Presentation at 2012 Leerink Swann Global Healthcare Conference | |
| 08.02.
| Sangamo BioSciences Reports Fourth Quarter and Full Year 2011 Financial Results | | 44 | PR Newswire |
| RICHMOND, Calif., Feb. 8, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported fourth quarter and full year 2011 financial results and accomplishments.
For the fourth quarter...
Mehr lesen zu:
Sangamo BioSciences Reports Fourth Quarter and Full Year 2011 Financial Results | |
| 01.02.
| Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast | | 133 | PR Newswire |
| RICHMOND, Calif., Feb. 1, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its fourth quarter and full year 2011 financial results on Wednesday...
Mehr lesen zu:
Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast | |
| 01.02.
| Sangamo (SGMO) Shares Rise Amid Deal with Shire (SHPGY) to Develop Therapeutics Treatment for Hemophilia | | 34 | StreetInsider.com |
| 01.02.
| Shire, Sangamo Team To Develop Therapeutics For Hemophilia, Monogenic Diseases | | 84 | AFX News |
| SAINT HELIER (dpa-AFX) - Sangamo BioSciences, Inc. (SGMO) announced that it
entered into a collaboration and license agreement with Shire plc (SHP.L, SHPGY)
to develop therapeutics for hemophilia...
Mehr lesen zu:
Shire, Sangamo Team To Develop Therapeutics For Hemophilia, Monogenic Diseases | |
